Author
Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....
Nosocomial Infections Market: By Products, By End Users, and Geography
Nosocomial Infections Market size was valued at US$ 4,281.1 million in 2022 and is expected to grow at a CAGR of 8.1% from 2022-2028. Nosocomial infections also referred to as healthcare-acquired infections (HAI), these infections are caused by bacteria, viruses, or fungi. Many infections can be acquired in clinical settings such as nursing homes, rehabilitation centers outpatient clinics, or other therapeutic settings. This can be obtained via an infected patient, the outside environment, or the facility's staff. Infections acquired in the hospital pose a danger to all patients. Hospital-acquired infections are more common in surgical patients, the elderly, and children. Among the most common infections include respiratory infections, surgical-site infections, gastrointestinal infections, urinary tract infections, bloodstream infections, cardiovascular drugs system infections, and bone and joint infections. Hospital-acquired diseases occur throughout the world, affecting both developed and developing countries, and are major causes of death among hospitalized patients. Furthermore, The rising number of nosocomial infection patients, the government's increasing number of regulations penalizing hospitals, extended hospitalization and antibody resistance, the growth of the medical tourism industry, and the prevalence of modernized healthcare infrastructure are some of the major and impactful factors that will likely drive the growth of the nosocomial infection market during the forecast period of. On the other hand, the advancement of various technologies and the increased number of research and development activities by various firms will create several chances, resulting in the expansion of the nosocomial infection market during the forecast period. However, one major impediment to the global market is a lack of awareness about nosocomial infections in low and middle-income countries. The market is primarily driven by an increase in the number of illnesses occurring in healthcare settings, particularly in developing nations with inadequate hygiene facilities. However, throughout the hospital-acquired infection diagnostics market projection, the drop in hospital-acquired infections in developed nations such as the United States, Germany, and the United Kingdom impedes the growth of the hospital-acquired infection diagnostics market.
Nosocomial Infections Market Key Developments:
In 2021, STERIS acquired Cantel, a global provider of infection prevention products and services, through a US subsidiary, to diversify its vast portfolio of sterilization services.
Study Period
2024-2030Base Year
2023CAGR
8.1%Largest Market
Asia PacificFastest Growing Market
North America
The number of surgical procedures performed worldwide has increased significantly throughout the years. Every year, around 235 million major surgical procedures are conducted worldwide, according to the WHO (2019). This is due to the rising frequency of obesity and other lifestyle disorders, an aging population, and an increase in spine injuries and sports-related injuries. As the number of surgical procedures performed grows, so does the demand for various surgical equipment and medical gadgets. Because of the demonstrated benefits of sterilized items and increased awareness about their usefulness in healthcare settings, this is projected to stimulate demand for the nosocomial infections market.
Report Benchmarks |
Details |
Report Study Period |
2024-2030 |
Market Size in 2022 |
US$ 4,281.1 million |
Market CAGR |
8.1% |
By Product Type |
|
By End User |
|
By Region |
|
Download Free Sample Report
Nosocomial Infections control consists of numerous products & services which are designed to prevent & control the spread of HAI infections originating from hospitals and other healthcare settings.
The increase in number of surgical procedures, rise in the incidence of hospital acquired infection, technological advancements in sterilization and disinfection technologies, surge in geriatric population, increase in government and non-government initiatives relating to spreading awareness concerning need for disinfection and need of proper hygiene are the major factors that boost the growth of the market.
Top companies such as Steris Plc (Cantel Medical Corporation), Getinge AB, 3M Company, Fortive (Advanced Sterilization Products), Sotera Health Llc, Belimed AG, and Ecolab Inc held a high market position in 2020. These key players held a high market position owing to the strong geographical foothold in different regions.
1. Executive Summary |
2. Global Nosocomial Infections Market Introduction |
2.1. Global Nosocomial Infections Market – Taxonomy |
2.2. Global Nosocomial Infections Market –Definitions |
2.2.1. By Product |
2.2.2. By End User |
2.2.3. By Region |
3. Global Nosocomial Infections Market Dynamics |
3.1. Drivers |
3.2. Restraints |
3.3. Opportunities/Unmet Needs of the Market |
3.4. Trends |
3.5. Global Nosocomial Infections Market Dynamic Factors - Impact Analysis |
3.6. Impact of COVID 19 on The Market |
3.7. Three Forecast Scenarios - Pessimistic, Conservative, and Opportunistic |
3.8. Mapping Market Player’s Activities |
3.9. Recent Key Developments |
3.10. Financial Status of the Market Players |
3.11. Recent Acquisitions, Collaborations, and Mergers |
4. Global Nosocomial Infections Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 |
4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) |
4.3. Market Opportunity Analysis |
5. Global Nosocomial Infections Market Forecast, By Product, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1. Heat Sterilization Equipment |
5.1.1. Moist Heat Sterilization Equipment |
5.1.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.1.3. Market Opportunity Analysis |
5.1.2. Dry Heat Sterilization Equipment |
5.1.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.1.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.1.2.3. Market Opportunity Analysis |
5.2. Low-Temperature Sterilization Equipment |
5.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.2.3. Market Opportunity Analysis |
5.3. Radiation Sterilization Equipment |
5.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.3.3. Market Opportunity Analysis |
5.4. Disinfection Equipment |
5.4.1. Disinfector |
5.4.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.1.3. Market Opportunity Analysis |
5.4.2. Endoscopic Reprocess or Systems |
5.4.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.2.3. Market Opportunity Analysis |
5.4.3. Disinfectants |
5.4.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
5.4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
5.4.3.3. Market Opportunity Analysis |
6. Global Nosocomial Infections Market Forecast, By End User, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1. Hospitals |
6.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.1.3. Market Opportunity Analysis |
6.2. Ambulatory Surgical Centers |
6.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.2.3. Market Opportunity Analysis |
6.3. Medical Institutions |
6.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.3.3. Market Opportunity Analysis |
6.4. Diagnostic Laboratories |
6.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.4.3. Market Opportunity Analysis |
6.5. Clinics |
6.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
6.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
6.5.3. Market Opportunity Analysis |
7. Global Nosocomial Infections Market Forecast, By Region, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1. North America |
7.1.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.1.3. Market Opportunity Analysis |
7.2. Europe |
7.2.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.2.3. Market Opportunity Analysis |
7.3. Asia-Pacific |
7.3.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.3.3. Market Opportunity Analysis |
7.4. Latin America |
7.4.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.4.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.4.3. Market Opportunity Analysis |
7.5. Middle East and Africa |
7.5.1. Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
7.5.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) |
7.5.3. Market Opportunity Analysis |
7.6. Global Nosocomial Infections Market - Opportunity Analysis Index, By Product, End User, and Region, 2022 - 2028 |
8. North America Nosocomial Infections Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
8.1. Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
8.1.1. Heat Sterilization Equipment |
8.1.1.1. Moist Heat Sterilization Equipment |
8.1.1.2. Dry Heat Sterilization Equipment |
8.1.2. Low-Temperature Sterilization Equipment |
8.1.3. Radiation Sterilization Equipment |
8.1.4. Disinfection Equipment |
8.1.4.1. Disinfector |
8.1.4.2. Endoscopic Reprocess or Systems |
8.1.4.3. Disinfectants |
8.2. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
8.2.1. Hospitals |
8.2.2. Ambulatory Surgical Centers |
8.2.3. Medical Institutions |
8.2.4. Diagnostic Laboratories |
8.2.5. Clinics |
8.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
8.3.1. USA |
8.3.2. Canada |
8.4. North America Nosocomial Infections Market - Opportunity Analysis Index, By Product, End User, and Country, 2022 - 2028 |
8.5. North America Nosocomial Infections Market Dynamics – Trends |
9. Europe Nosocomial Infections Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
9.1. Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
9.1.1. Heat Sterilization Equipment |
9.1.1.1. Moist Heat Sterilization Equipment |
9.1.1.2. Dry Heat Sterilization Equipment |
9.1.2. Low-Temperature Sterilization Equipment |
9.1.3. Radiation Sterilization Equipment |
9.1.4. Disinfection Equipment |
9.1.4.1. Disinfector |
9.1.4.2. Endoscopic Reprocess or Systems |
9.1.4.3. Disinfectants |
9.2. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
9.2.1. Hospitals |
9.2.2. Ambulatory Surgical Centers |
9.2.3. Medical Institutions |
9.2.4. Diagnostic Laboratories |
9.2.5. Clinics |
9.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
9.3.1. Germany |
9.3.2. UK |
9.3.3. France |
9.3.4. Italy |
9.3.5. Spain |
9.3.6. Rest of Europe |
9.4. Europe Nosocomial Infections Market - Opportunity Analysis Index, By Product, End User, and Country, 2022 - 2028 |
9.5. Europe Nosocomial Infections Market Dynamics – Trends |
10. Asia-Pacific Nosocomial Infections Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
10.1. Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.1.1. Heat Sterilization Equipment |
10.1.1.1. Moist Heat Sterilization Equipment |
10.1.1.2. Dry Heat Sterilization Equipment |
10.1.2. Low-Temperature Sterilization Equipment |
10.1.3. Radiation Sterilization Equipment |
10.1.4. Disinfection Equipment |
10.1.4.1. Disinfector |
10.1.4.2. Endoscopic Reprocess or Systems |
10.1.4.3. Disinfectants |
10.2. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
10.2.1. Hospitals |
10.2.2. Ambulatory Surgical Centers |
10.2.3. Medical Institutions |
10.2.4. Diagnostic Laboratories |
10.2.5. Clinics |
10.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
10.3.1. Japan |
10.3.2. China |
10.3.3. India |
10.3.4. ASEAN |
10.3.5. Rest of Asia-Pacific |
10.4. Asia-Pacific Nosocomial Infections Market - Opportunity Analysis Index, By Product, End User, and Country, 2022 - 2028 |
10.5. Asia-Pacific Nosocomial Infections Market Dynamics – Trends |
11. Latin America Nosocomial Infections Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
11.1. Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.1.1. Heat Sterilization Equipment |
11.1.1.1. Moist Heat Sterilization Equipment |
11.1.1.2. Dry Heat Sterilization Equipment |
11.1.2. Low-Temperature Sterilization Equipment |
11.1.3. Radiation Sterilization Equipment |
11.1.4. Disinfection Equipment |
11.1.4.1. Disinfector |
11.1.4.2. Endoscopic Reprocess or Systems |
11.1.4.3. Disinfectants |
11.2. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
11.2.1. Hospitals |
11.2.2. Ambulatory Surgical Centers |
11.2.3. Medical Institutions |
11.2.4. Diagnostic Laboratories |
11.2.5. Clinics |
11.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
11.3.1. Brazil |
11.3.2. Argentina |
11.3.3. Rest of Latin America |
11.4. Latin America Nosocomial Infections Market - Opportunity Analysis Index, By Product, End User, and Country, 2022 - 2028 |
11.5. Latin America Nosocomial Infections Market Dynamics – Trends |
12. Middle East and Africa Nosocomial Infections Market Analysis, 2017 - 2021 and Forecast, 2022 - 2028 (Revenue, USD Million) |
12.1. Product Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.1.1. Heat Sterilization Equipment |
12.1.1.1. Moist Heat Sterilization Equipment |
12.1.1.2. Dry Heat Sterilization Equipment |
12.1.2. Low-Temperature Sterilization Equipment |
12.1.3. Radiation Sterilization Equipment |
12.1.4. Disinfection Equipment |
12.1.4.1. Disinfector |
12.1.4.2. Endoscopic Reprocess or Systems |
12.1.4.3. Disinfectants |
12.2. End User Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million), Y-o-Y Growth (%), and Market Share (%) |
12.2.1. Hospitals |
12.2.2. Ambulatory Surgical Centers |
12.2.3. Medical Institutions |
12.2.4. Diagnostic Laboratories |
12.2.5. Clinics |
12.3. Country Analysis 2017 - 2021 and Forecast 2022 - 2028 by Revenue (USD Million) Y-o-Y Growth (%) and Market Share (%) |
12.3.1. Saudi Arabia |
12.3.2. GCC Countries |
12.3.3. South Africa |
12.3.4. Rest of MEA |
12.4. MEA Nosocomial Infections Market - Opportunity Analysis Index, By Product, End User, and Country, 2022 - 2028 |
12.5. MEA Nosocomial Infections Market Dynamics – Trends |
13. Competition Landscape |
13.1. Strategic Dashboard of Top Market Players |
13.2. Company Profiles (Introduction, Financial Analysis, Product Products, Key Developments, Strategies, and SWOT Analysis) |
13.2.1. STERIS plc (US) |
13.2.2. Sotera Health Company (US) |
13.2.3. Getinge AB (Sweden) |
13.2.4. Advanced Sterilization Products (ASP) (US) |
13.2.5. Ecolab Inc. (US) |
13.2.6. 3M Company (US) |
13.2.7. MATACHANA GROUP (Spain) |
13.2.8. MMM Group (Germany) |
13.2.9. Belimed AG (Switzerland) |
13.2.10. Reckitt Benckiser (UK) |
13.2.11. Metrex Research LLC (UK) |
13.2.12. Miele Group (Germany) |
13.2.13. Pal International (UK) |
13.2.14. MELAG Medizintechnik GmbH & Co. KG (Germany) |
13.2.15. Contec, Inc. (US) |
14. Research Methodology |
15. Key Assumptions and Acronyms |
Key Market Players